Vendor:Cannevert Therapeutics Ltd. - Revision history

Move page script: Move page script moved page Cannevert Therapeutics Ltd. to Vendor:Cannevert Therapeutics Ltd. without leaving a redirect

2024-03-27T18:57:29Z

Move page script moved page Cannevert Therapeutics Ltd. to Vendor:Cannevert Therapeutics Ltd. without leaving a redirect

← Older revision		Revision as of 18:57, 27 March 2024
Line 12:		Line 12:
	\|foundation =		\|foundation =
	\|founder =		\|founder =
	\|defunct =		\|defunct = May 2019<ref name="GNWVeritas19" />
	\|location_city = 101-2386 East Mall, Vancouver, British Columbia		\|location_city = 101-2386 East Mall, Vancouver, British Columbia
	\|location_country = Canada		\|location_country = Canada
Line 32:		Line 32:
	\|divisions =		\|divisions =
	\|subsid =		\|subsid =
	\|homepage = [~~https~~://~~anandia~~.ca/ ~~anandia~~.ca]		\|homepage = [http://www.cannevert.com/home.html cannevert.com]
	\|linkedin = ~~[https://www.linkedin.com/company/anandia-labs/ https://www.linkedin.com/company/anandia-labs/]~~		\|linkedin =
	\|footnotes =		\|footnotes =
	\|intl = No		\|intl = No
	}}		}}

	'''Cannevert Therapeutics Ltd.''' ~~conducts~~ ''[[Cannabis]]'' research and ~~performs~~ chemical ''Cannabis'' [[laboratory]] testing for the country's various cannabis programs.<ref name="GoCLab18">{{cite web \|url=https://www.canada.ca/en/health-canada/services/list-licensed-dealers.html \|title=Laboratories licensed to conduct activities with cannabis \|work=Health Canada \|publisher=Government of Canada \|date=17 August 2018 \|accessdate=27 June 2019}}</ref>		'''Cannevert Therapeutics Ltd.''' conducted ''[[Cannabis]]'' research and performed chemical ''Cannabis'' [[laboratory]] testing for the country's various cannabis programs.<ref name="GoCLab18">{{cite web \|url=https://www.canada.ca/en/health-canada/services/list-licensed-dealers.html \|title=Laboratories licensed to conduct activities with cannabis \|work=Health Canada \|publisher=Government of Canada \|date=17 August 2018 \|accessdate=27 June 2019}}</ref> However, the entity appears to have been a victim of downsizing by parent Veritas Pharma, Inc. in 2019 and no longer appears to operate.

	==History==		==History==
	The company was formally founded in June 2014.<ref name="CACLACan">{{cite web \|url=https://beta.canadasbusinessregistries.ca/search/results?search={Cannevert}&status=Active \|title=Cannevert Therapeutics Ltd \|work=Canada's Business Registries \|publisher=Canadian Association of Corporate Law Administrators \|accessdate=28 June 2019}}</ref> In December 2015, Veritas Pharma, Inc., "an early stage pharmaceutical company developing innovative medicinal cannabis cultivars for specific disease conditions," announced it would begin investing in Cannevert.<ref name="VeritasVeritas16">{{cite web \|url=http://veritaspharmainc.com/2016/02/16/veritas-presents-its-key-cannevert-scientists/ \|title=Veritas Presents Its Key Cannevert Scientists \|publisher=Veritas Pharma, Inc \|date=16 February 2016}}</ref> By May 2017, Veritas owned 80 percent of Cannevert, with an option to wholly buy the company on the table.<ref name="TNVeritas17">{{cite web \|url=https://thenewswire.com/archives/BKRFNmWA-veritas-pharma-places-final-payment-in-trust-for-the-acquisition-of-cannevert-therapeutics.html \|title=Veritas Pharma Places final Payment in Trust for the Acquisition of Cannevert Therapeutics \|author=Veritas Pharma, Inc \|work=TheNewswire \|date=25 January 2017 \|accessdate=28 June 2019}}</ref> In March 2018, Veritas announced the full acquisition of Cannevert, stating that the acquisition "will further enhance and extend the Company's product offering through development of the most effective cannabis strains, advancing the science behind medical cannabis, providing distribution channels for the Companies patent protected IP (cultivars & strains) products and sell or license to cancer clinics, in Canada, the US, and Europe."<ref name="GNWVeritas18">{{cite web \|url=https://www.globenewswire.com/news-release/2018/03/21/1443325/0/en/Veritas-Pharma-Completes-the-100-Takeover-of-Cannevert-Therapeutics.html \|title=Veritas Pharma Completes the 100% Takeover of Cannevert Therapeutics \|author=Veritas Pharma, Inc \|work=GlobeNewswire \|date=21 March 2018 \|accessdate=28 June 2019}}</ref> In May 2019, Veritas announced a restructuring and rebuilding of Cannevert, one that would include cutting and rehiring some researchers on a contract basis. Veritas described the move as one that would "reduce costs" while scaling to better tackle analytical testing of ''Cannabis''.<ref name="GNWVeritas19">{{cite web \|url=https://www.globenewswire.com/news-release/2019/05/15/1825699/0/en/Veritas-Announces-Restructuring-of-Cannevert-Therapeutics-Ltd.html \|title=Veritas Announces Restructuring of Cannevert Therapeutics Ltd. \|author=Veritas Pharma, Inc \|work=GlobeNewswire \|date=15 May 2019 \|accessdate=28 June 2019}}</ref>		The company was formally founded in June 2014.<ref name="CACLACan">{{cite web \|url=https://beta.canadasbusinessregistries.ca/search/results?search={Cannevert}&status=Active \|title=Cannevert Therapeutics Ltd \|work=Canada's Business Registries \|publisher=Canadian Association of Corporate Law Administrators \|accessdate=28 June 2019}}</ref> In December 2015, Veritas Pharma, Inc., "an early stage pharmaceutical company developing innovative medicinal cannabis cultivars for specific disease conditions," announced it would begin investing in Cannevert.<ref name="VeritasVeritas16">{{cite web \|url=http://veritaspharmainc.com/2016/02/16/veritas-presents-its-key-cannevert-scientists/ \|title=Veritas Presents Its Key Cannevert Scientists \|publisher=Veritas Pharma, Inc \|date=16 February 2016}}</ref> By May 2017, Veritas owned 80 percent of Cannevert, with an option to wholly buy the company on the table.<ref name="TNVeritas17">{{cite web \|url=https://thenewswire.com/archives/BKRFNmWA-veritas-pharma-places-final-payment-in-trust-for-the-acquisition-of-cannevert-therapeutics.html \|title=Veritas Pharma Places final Payment in Trust for the Acquisition of Cannevert Therapeutics \|author=Veritas Pharma, Inc \|work=TheNewswire \|date=25 January 2017 \|accessdate=28 June 2019}}</ref> In March 2018, Veritas announced the full acquisition of Cannevert, stating that the acquisition "will further enhance and extend the Company's product offering through development of the most effective cannabis strains, advancing the science behind medical cannabis, providing distribution channels for the Companies patent protected IP (cultivars & strains) products and sell or license to cancer clinics, in Canada, the US, and Europe."<ref name="GNWVeritas18">{{cite web \|url=https://www.globenewswire.com/news-release/2018/03/21/1443325/0/en/Veritas-Pharma-Completes-the-100-Takeover-of-Cannevert-Therapeutics.html \|title=Veritas Pharma Completes the 100% Takeover of Cannevert Therapeutics \|author=Veritas Pharma, Inc \|work=GlobeNewswire \|date=21 March 2018 \|accessdate=28 June 2019}}</ref>

	==~~Locations==~~		In May 2019, Veritas announced a restructuring and rebuilding of Cannevert, one that would include cutting and rehiring some researchers on a contract basis. Veritas described the move as one that would "reduce costs" while scaling to better tackle analytical testing of ''Cannabis''.<ref name="GNWVeritas19">{{cite web \|url=https://www.globenewswire.com/news-release/2019/05/15/1825699/0/en/Veritas-Announces-Restructuring-of-Cannevert-Therapeutics-Ltd.html \|title=Veritas Announces Restructuring of Cannevert Therapeutics Ltd. \|author=Veritas Pharma, Inc \|work=GlobeNewswire \|date=15 May 2019 \|accessdate=28 June 2019}}</ref>
	~~The following laboratory locations are known. Services may vary among locations:~~

	* [http://www.~~cannevert~~.com/~~contact~~-us.html Cannevert Therapeutics~~] - Vancouver~~, ~~British Columbia~~

	==~~Pricing~~==
	~~The company doesn't make its cannabis testing pricing public.~~

	==Additional information==		==Additional information==
Line 58:		Line 52:

	<!---Place all category tags here-->		<!---Place all category tags here-->
	[[Category:~~Cannabis testing laboratories]]~~		[[Category:Inactive vendors]]
	~~[[Category:Labs in British Columbia]]~~
	~~[[Category:Labs in Canada]]~~
	~~[[Category:Vendors~~]]

Shawndouglas: Finished adding rest of content.

2023-12-28T17:22:38Z

Finished adding rest of content.

← Older revision		Revision as of 17:22, 28 December 2023
Line 2:		Line 2:
	\|company_name = '''Cannevert Therapeutics Ltd.'''		\|company_name = '''Cannevert Therapeutics Ltd.'''
	\|company_logo =		\|company_logo =
	\|company_type = Incorporated (~~inc.~~)		\|company_type = Incorporated (limited)
	\|traded_as =		\|traded_as =
	\|industry = [[Cannabis industry]]		\|industry = [[Cannabis industry]]
	\|genre = ''Cannabis'' testing		\|genre = ''Cannabis'' testing and research
	\|fate =		\|fate =
	\|predecessor =		\|predecessor =
Line 13:		Line 13:
	\|founder =		\|founder =
	\|defunct =		\|defunct =
	\|location_city = ~~#322~~ - ~~2250 Lower~~ Mall, Vancouver, British Columbia		\|location_city = 101-2386 East Mall, Vancouver, British Columbia
	\|location_country = Canada		\|location_country = Canada
	\|locations = 1		\|locations = 1
Line 20:		Line 20:
	\|products =		\|products =
	\|production =		\|production =
	\|services = ''Cannabis'' testing		\|services = ''Cannabis'' testing and research
	\|revenue =		\|revenue =
	\|operating_income =		\|operating_income =
Line 29:		Line 29:
	\|owner =		\|owner =
	\|num_employees =		\|num_employees =
	\|parent =		\|parent = Veritas Pharma, Inc.
	\|divisions =		\|divisions =
	\|subsid =		\|subsid =
Line 38:		Line 38:
	}}		}}

	'''Cannevert Therapeutics Ltd.''' ~~performs chemical~~ ''[[Cannabis]]'' [[laboratory]] testing for the country's various cannabis programs.<ref name="GoCLab18">{{cite web \|url=https://www.canada.ca/en/health-canada/services/list-licensed-dealers.html \|title=Laboratories licensed to conduct activities with cannabis \|work=Health Canada \|publisher=Government of Canada \|date=17 August 2018 \|accessdate=27 June 2019}}</ref>		'''Cannevert Therapeutics Ltd.''' conducts ''[[Cannabis]]'' research and performs chemical ''Cannabis'' [[laboratory]] testing for the country's various cannabis programs.<ref name="GoCLab18">{{cite web \|url=https://www.canada.ca/en/health-canada/services/list-licensed-dealers.html \|title=Laboratories licensed to conduct activities with cannabis \|work=Health Canada \|publisher=Government of Canada \|date=17 August 2018 \|accessdate=27 June 2019}}</ref>

	==History==		==History==
Line 46:		Line 46:
	The following laboratory locations are known. Services may vary among locations:		The following laboratory locations are known. Services may vary among locations:

	* [~~https~~://~~anandia~~.ca/contact~~/ Anandia Laboratories~~] - Vancouver, British Columbia		* [http://www.cannevert.com/contact-us.html Cannevert Therapeutics] - Vancouver, British Columbia

	==Pricing==		==Pricing==
Line 52:		Line 52:

	==Additional information==		==Additional information==
	* [https://anandia.ca/#services Anandia services]

	==References==		==References==

Shawndouglas: Saving and adding more.

2023-12-28T17:18:42Z

Saving and adding more.

← Older revision		Revision as of 17:18, 28 December 2023
Line 2:		Line 2:
	\|company_name = '''Cannevert Therapeutics Ltd.'''		\|company_name = '''Cannevert Therapeutics Ltd.'''
	\|company_logo =		\|company_logo =
	\|company_type = Incorporated (~~limited~~)		\|company_type = Incorporated (inc.)
	\|traded_as =		\|traded_as =
	\|industry = [[Cannabis industry]]		\|industry = [[Cannabis industry]]
	\|genre = ''Cannabis'' testing ~~and research~~		\|genre = ''Cannabis'' testing
	\|fate =		\|fate =
	\|predecessor =		\|predecessor =
Line 12:		Line 12:
	\|foundation =		\|foundation =
	\|founder =		\|founder =
	\|defunct = ~~May 2019<ref name="GNWVeritas19" />~~		\|defunct =
	\|location_city = ~~101~~-~~2386 East~~ Mall, Vancouver, British Columbia		\|location_city = #322 - 2250 Lower Mall, Vancouver, British Columbia
	\|location_country = Canada		\|location_country = Canada
	\|locations = 1		\|locations = 1
Line 20:		Line 20:
	\|products =		\|products =
	\|production =		\|production =
	\|services = ''Cannabis'' testing ~~and research~~		\|services = ''Cannabis'' testing
	\|revenue =		\|revenue =
	\|operating_income =		\|operating_income =
Line 29:		Line 29:
	\|owner =		\|owner =
	\|num_employees =		\|num_employees =
	\|parent = ~~Veritas Pharma, Inc.~~		\|parent =
	\|divisions =		\|divisions =
	\|subsid =		\|subsid =
	\|homepage = [~~http~~://~~www.cannevert~~.~~com~~/~~home~~.~~html cannevert.com~~]		\|homepage = [https://anandia.ca/ anandia.ca]
	\|linkedin =		\|linkedin = [https://www.linkedin.com/company/anandia-labs/ https://www.linkedin.com/company/anandia-labs/]
	\|footnotes =		\|footnotes =
	\|intl = No		\|intl = No
	}}		}}

	'''Cannevert Therapeutics Ltd.''' ~~conducted~~ ''[[Cannabis]]~~'' research and performed chemical ''Cannabis~~'' [[laboratory]] testing for the country's various cannabis programs.<ref name="GoCLab18">{{cite web \|url=https://www.canada.ca/en/health-canada/services/list-licensed-dealers.html \|title=Laboratories licensed to conduct activities with cannabis \|work=Health Canada \|publisher=Government of Canada \|date=17 August 2018 \|accessdate=27 June 2019}}</ref> ~~However, the entity appears to have been a victim of downsizing by parent Veritas Pharma, Inc. in 2019 and no longer appears to operate.~~		'''Cannevert Therapeutics Ltd.''' performs chemical ''[[Cannabis]]'' [[laboratory]] testing for the country's various cannabis programs.<ref name="GoCLab18">{{cite web \|url=https://www.canada.ca/en/health-canada/services/list-licensed-dealers.html \|title=Laboratories licensed to conduct activities with cannabis \|work=Health Canada \|publisher=Government of Canada \|date=17 August 2018 \|accessdate=27 June 2019}}</ref>

	==History==		==History==
	The company was formally founded in June 2014.<ref name="CACLACan">{{cite web \|url=https://beta.canadasbusinessregistries.ca/search/results?search={Cannevert}&status=Active \|title=Cannevert Therapeutics Ltd \|work=Canada's Business Registries \|publisher=Canadian Association of Corporate Law Administrators \|accessdate=28 June 2019}}</ref> In December 2015, Veritas Pharma, Inc., "an early stage pharmaceutical company developing innovative medicinal cannabis cultivars for specific disease conditions," announced it would begin investing in Cannevert.<ref name="VeritasVeritas16">{{cite web \|url=http://veritaspharmainc.com/2016/02/16/veritas-presents-its-key-cannevert-scientists/ \|title=Veritas Presents Its Key Cannevert Scientists \|publisher=Veritas Pharma, Inc \|date=16 February 2016}}</ref> By May 2017, Veritas owned 80 percent of Cannevert, with an option to wholly buy the company on the table.<ref name="TNVeritas17">{{cite web \|url=https://thenewswire.com/archives/BKRFNmWA-veritas-pharma-places-final-payment-in-trust-for-the-acquisition-of-cannevert-therapeutics.html \|title=Veritas Pharma Places final Payment in Trust for the Acquisition of Cannevert Therapeutics \|author=Veritas Pharma, Inc \|work=TheNewswire \|date=25 January 2017 \|accessdate=28 June 2019}}</ref> In March 2018, Veritas announced the full acquisition of Cannevert, stating that the acquisition "will further enhance and extend the Company's product offering through development of the most effective cannabis strains, advancing the science behind medical cannabis, providing distribution channels for the Companies patent protected IP (cultivars & strains) products and sell or license to cancer clinics, in Canada, the US, and Europe."<ref name="GNWVeritas18">{{cite web \|url=https://www.globenewswire.com/news-release/2018/03/21/1443325/0/en/Veritas-Pharma-Completes-the-100-Takeover-of-Cannevert-Therapeutics.html \|title=Veritas Pharma Completes the 100% Takeover of Cannevert Therapeutics \|author=Veritas Pharma, Inc \|work=GlobeNewswire \|date=21 March 2018 \|accessdate=28 June 2019}}</ref>		The company was formally founded in June 2014.<ref name="CACLACan">{{cite web \|url=https://beta.canadasbusinessregistries.ca/search/results?search={Cannevert}&status=Active \|title=Cannevert Therapeutics Ltd \|work=Canada's Business Registries \|publisher=Canadian Association of Corporate Law Administrators \|accessdate=28 June 2019}}</ref> In December 2015, Veritas Pharma, Inc., "an early stage pharmaceutical company developing innovative medicinal cannabis cultivars for specific disease conditions," announced it would begin investing in Cannevert.<ref name="VeritasVeritas16">{{cite web \|url=http://veritaspharmainc.com/2016/02/16/veritas-presents-its-key-cannevert-scientists/ \|title=Veritas Presents Its Key Cannevert Scientists \|publisher=Veritas Pharma, Inc \|date=16 February 2016}}</ref> By May 2017, Veritas owned 80 percent of Cannevert, with an option to wholly buy the company on the table.<ref name="TNVeritas17">{{cite web \|url=https://thenewswire.com/archives/BKRFNmWA-veritas-pharma-places-final-payment-in-trust-for-the-acquisition-of-cannevert-therapeutics.html \|title=Veritas Pharma Places final Payment in Trust for the Acquisition of Cannevert Therapeutics \|author=Veritas Pharma, Inc \|work=TheNewswire \|date=25 January 2017 \|accessdate=28 June 2019}}</ref> In March 2018, Veritas announced the full acquisition of Cannevert, stating that the acquisition "will further enhance and extend the Company's product offering through development of the most effective cannabis strains, advancing the science behind medical cannabis, providing distribution channels for the Companies patent protected IP (cultivars & strains) products and sell or license to cancer clinics, in Canada, the US, and Europe."<ref name="GNWVeritas18">{{cite web \|url=https://www.globenewswire.com/news-release/2018/03/21/1443325/0/en/Veritas-Pharma-Completes-the-100-Takeover-of-Cannevert-Therapeutics.html \|title=Veritas Pharma Completes the 100% Takeover of Cannevert Therapeutics \|author=Veritas Pharma, Inc \|work=GlobeNewswire \|date=21 March 2018 \|accessdate=28 June 2019}}</ref> In May 2019, Veritas announced a restructuring and rebuilding of Cannevert, one that would include cutting and rehiring some researchers on a contract basis. Veritas described the move as one that would "reduce costs" while scaling to better tackle analytical testing of ''Cannabis''.<ref name="GNWVeritas19">{{cite web \|url=https://www.globenewswire.com/news-release/2019/05/15/1825699/0/en/Veritas-Announces-Restructuring-of-Cannevert-Therapeutics-Ltd.html \|title=Veritas Announces Restructuring of Cannevert Therapeutics Ltd. \|author=Veritas Pharma, Inc \|work=GlobeNewswire \|date=15 May 2019 \|accessdate=28 June 2019}}</ref>

	In May 2019, Veritas announced a restructuring and rebuilding of Cannevert, one that would include cutting and rehiring some researchers on a contract basis. Veritas described the move as one that would "reduce costs" while scaling to better tackle analytical testing of ''Cannabis''.<ref name=~~"GNWVeritas19">{{cite web \|url~~=https://~~www~~.~~globenewswire.com~~/~~news-release/2019/05~~/~~15/1825699/0/en/Veritas~~-~~Announces-Restructuring-of-Cannevert-Therapeutics-Ltd.html \|title~~=~~Veritas Announces Restructuring of Cannevert Therapeutics Ltd. \|author~~=~~Veritas Pharma, Inc \|work~~=~~GlobeNewswire \|date~~=~~15 May 2019 \|accessdate=28 June 2019}}</ref>~~		==Locations==
			The following laboratory locations are known. Services may vary among locations:

			* [https://anandia.ca/contact/ Anandia Laboratories] - Vancouver, British Columbia

			==Pricing==
			The company doesn't make its cannabis testing pricing public.

	==Additional information==		==Additional information==
			* [https://anandia.ca/#services Anandia services]

	==References==		==References==
Line 52:		Line 58:

	<!---Place all category tags here-->		<!---Place all category tags here-->
	[[Category:~~Inactive vendors~~]]		[[Category:Cannabis testing laboratories]]
			[[Category:Labs in British Columbia]]
			[[Category:Labs in Canada]]
			[[Category:Vendors]]

Shawndouglas: Updated due to website changes

2023-12-27T23:56:31Z

Updated due to website changes

← Older revision		Revision as of 23:56, 27 December 2023
Line 12:		Line 12:
	\|foundation =		\|foundation =
	\|founder =		\|founder =
	\|defunct =		\|defunct = May 2019<ref name="GNWVeritas19" />
	\|location_city = 101-2386 East Mall, Vancouver, British Columbia		\|location_city = 101-2386 East Mall, Vancouver, British Columbia
	\|location_country = Canada		\|location_country = Canada
Line 32:		Line 32:
	\|divisions =		\|divisions =
	\|subsid =		\|subsid =
	\|homepage = [~~https~~://~~anandia~~.ca/ ~~anandia~~.ca]		\|homepage = [http://www.cannevert.com/home.html cannevert.com]
	\|linkedin = ~~[https://www.linkedin.com/company/anandia-labs/ https://www.linkedin.com/company/anandia-labs/]~~		\|linkedin =
	\|footnotes =		\|footnotes =
	\|intl = No		\|intl = No
	}}		}}

	'''Cannevert Therapeutics Ltd.''' ~~conducts~~ ''[[Cannabis]]'' research and ~~performs~~ chemical ''Cannabis'' [[laboratory]] testing for the country's various cannabis programs.<ref name="GoCLab18">{{cite web \|url=https://www.canada.ca/en/health-canada/services/list-licensed-dealers.html \|title=Laboratories licensed to conduct activities with cannabis \|work=Health Canada \|publisher=Government of Canada \|date=17 August 2018 \|accessdate=27 June 2019}}</ref>		'''Cannevert Therapeutics Ltd.''' conducted ''[[Cannabis]]'' research and performed chemical ''Cannabis'' [[laboratory]] testing for the country's various cannabis programs.<ref name="GoCLab18">{{cite web \|url=https://www.canada.ca/en/health-canada/services/list-licensed-dealers.html \|title=Laboratories licensed to conduct activities with cannabis \|work=Health Canada \|publisher=Government of Canada \|date=17 August 2018 \|accessdate=27 June 2019}}</ref> However, the entity appears to have been a victim of downsizing by parent Veritas Pharma, Inc. in 2019 and no longer appears to operate.

	==History==		==History==
	The company was formally founded in June 2014.<ref name="CACLACan">{{cite web \|url=https://beta.canadasbusinessregistries.ca/search/results?search={Cannevert}&status=Active \|title=Cannevert Therapeutics Ltd \|work=Canada's Business Registries \|publisher=Canadian Association of Corporate Law Administrators \|accessdate=28 June 2019}}</ref> In December 2015, Veritas Pharma, Inc., "an early stage pharmaceutical company developing innovative medicinal cannabis cultivars for specific disease conditions," announced it would begin investing in Cannevert.<ref name="VeritasVeritas16">{{cite web \|url=http://veritaspharmainc.com/2016/02/16/veritas-presents-its-key-cannevert-scientists/ \|title=Veritas Presents Its Key Cannevert Scientists \|publisher=Veritas Pharma, Inc \|date=16 February 2016}}</ref> By May 2017, Veritas owned 80 percent of Cannevert, with an option to wholly buy the company on the table.<ref name="TNVeritas17">{{cite web \|url=https://thenewswire.com/archives/BKRFNmWA-veritas-pharma-places-final-payment-in-trust-for-the-acquisition-of-cannevert-therapeutics.html \|title=Veritas Pharma Places final Payment in Trust for the Acquisition of Cannevert Therapeutics \|author=Veritas Pharma, Inc \|work=TheNewswire \|date=25 January 2017 \|accessdate=28 June 2019}}</ref> In March 2018, Veritas announced the full acquisition of Cannevert, stating that the acquisition "will further enhance and extend the Company's product offering through development of the most effective cannabis strains, advancing the science behind medical cannabis, providing distribution channels for the Companies patent protected IP (cultivars & strains) products and sell or license to cancer clinics, in Canada, the US, and Europe."<ref name="GNWVeritas18">{{cite web \|url=https://www.globenewswire.com/news-release/2018/03/21/1443325/0/en/Veritas-Pharma-Completes-the-100-Takeover-of-Cannevert-Therapeutics.html \|title=Veritas Pharma Completes the 100% Takeover of Cannevert Therapeutics \|author=Veritas Pharma, Inc \|work=GlobeNewswire \|date=21 March 2018 \|accessdate=28 June 2019}}</ref> In May 2019, Veritas announced a restructuring and rebuilding of Cannevert, one that would include cutting and rehiring some researchers on a contract basis. Veritas described the move as one that would "reduce costs" while scaling to better tackle analytical testing of ''Cannabis''.<ref name="GNWVeritas19">{{cite web \|url=https://www.globenewswire.com/news-release/2019/05/15/1825699/0/en/Veritas-Announces-Restructuring-of-Cannevert-Therapeutics-Ltd.html \|title=Veritas Announces Restructuring of Cannevert Therapeutics Ltd. \|author=Veritas Pharma, Inc \|work=GlobeNewswire \|date=15 May 2019 \|accessdate=28 June 2019}}</ref>		The company was formally founded in June 2014.<ref name="CACLACan">{{cite web \|url=https://beta.canadasbusinessregistries.ca/search/results?search={Cannevert}&status=Active \|title=Cannevert Therapeutics Ltd \|work=Canada's Business Registries \|publisher=Canadian Association of Corporate Law Administrators \|accessdate=28 June 2019}}</ref> In December 2015, Veritas Pharma, Inc., "an early stage pharmaceutical company developing innovative medicinal cannabis cultivars for specific disease conditions," announced it would begin investing in Cannevert.<ref name="VeritasVeritas16">{{cite web \|url=http://veritaspharmainc.com/2016/02/16/veritas-presents-its-key-cannevert-scientists/ \|title=Veritas Presents Its Key Cannevert Scientists \|publisher=Veritas Pharma, Inc \|date=16 February 2016}}</ref> By May 2017, Veritas owned 80 percent of Cannevert, with an option to wholly buy the company on the table.<ref name="TNVeritas17">{{cite web \|url=https://thenewswire.com/archives/BKRFNmWA-veritas-pharma-places-final-payment-in-trust-for-the-acquisition-of-cannevert-therapeutics.html \|title=Veritas Pharma Places final Payment in Trust for the Acquisition of Cannevert Therapeutics \|author=Veritas Pharma, Inc \|work=TheNewswire \|date=25 January 2017 \|accessdate=28 June 2019}}</ref> In March 2018, Veritas announced the full acquisition of Cannevert, stating that the acquisition "will further enhance and extend the Company's product offering through development of the most effective cannabis strains, advancing the science behind medical cannabis, providing distribution channels for the Companies patent protected IP (cultivars & strains) products and sell or license to cancer clinics, in Canada, the US, and Europe."<ref name="GNWVeritas18">{{cite web \|url=https://www.globenewswire.com/news-release/2018/03/21/1443325/0/en/Veritas-Pharma-Completes-the-100-Takeover-of-Cannevert-Therapeutics.html \|title=Veritas Pharma Completes the 100% Takeover of Cannevert Therapeutics \|author=Veritas Pharma, Inc \|work=GlobeNewswire \|date=21 March 2018 \|accessdate=28 June 2019}}</ref>

	==~~Locations==~~		In May 2019, Veritas announced a restructuring and rebuilding of Cannevert, one that would include cutting and rehiring some researchers on a contract basis. Veritas described the move as one that would "reduce costs" while scaling to better tackle analytical testing of ''Cannabis''.<ref name="GNWVeritas19">{{cite web \|url=https://www.globenewswire.com/news-release/2019/05/15/1825699/0/en/Veritas-Announces-Restructuring-of-Cannevert-Therapeutics-Ltd.html \|title=Veritas Announces Restructuring of Cannevert Therapeutics Ltd. \|author=Veritas Pharma, Inc \|work=GlobeNewswire \|date=15 May 2019 \|accessdate=28 June 2019}}</ref>
	~~The following laboratory locations are known. Services may vary among locations:~~

	* [http://www.~~cannevert~~.com/~~contact~~-us.html Cannevert Therapeutics~~] - Vancouver~~, ~~British Columbia~~

	==~~Pricing~~==
	~~The company doesn't make its cannabis testing pricing public.~~

	==Additional information==		==Additional information==
Line 58:		Line 52:

	<!---Place all category tags here-->		<!---Place all category tags here-->
	[[Category:~~Cannabis testing laboratories]]~~		[[Category:Inactive vendors]]
	~~[[Category:Labs in British Columbia]]~~
	~~[[Category:Labs in Canada]]~~
	~~[[Category:Vendors~~]]

Shawndouglas: 3 revisions imported

2023-12-27T22:29:42Z

3 revisions imported

← Older revision		Revision as of 22:29, 27 December 2023
Line 12:		Line 12:
	\|foundation =		\|foundation =
	\|founder =		\|founder =
	\|defunct = ~~May 2019<ref name="GNWVeritas19" />~~		\|defunct =
	\|location_city = 101-2386 East Mall, Vancouver, British Columbia		\|location_city = 101-2386 East Mall, Vancouver, British Columbia
	\|location_country = Canada		\|location_country = Canada
Line 32:		Line 32:
	\|divisions =		\|divisions =
	\|subsid =		\|subsid =
	\|homepage = [~~http~~://~~www.cannevert~~.~~com~~/~~home~~.~~html cannevert.com~~]		\|homepage = [https://anandia.ca/ anandia.ca]
	\|linkedin =		\|linkedin = [https://www.linkedin.com/company/anandia-labs/ https://www.linkedin.com/company/anandia-labs/]
	\|footnotes =		\|footnotes =
	\|intl = No		\|intl = No
	}}		}}

	'''Cannevert Therapeutics Ltd.''' ~~conducted~~ ''[[Cannabis]]'' research and ~~performed~~ chemical ''Cannabis'' [[laboratory]] testing for the country's various cannabis programs.<ref name="GoCLab18">{{cite web \|url=https://www.canada.ca/en/health-canada/services/list-licensed-dealers.html \|title=Laboratories licensed to conduct activities with cannabis \|work=Health Canada \|publisher=Government of Canada \|date=17 August 2018 \|accessdate=27 June 2019}}</ref> ~~However, the entity appears to have been a victim of downsizing by parent Veritas Pharma, Inc. in 2019 and no longer appears to operate.~~		'''Cannevert Therapeutics Ltd.''' conducts ''[[Cannabis]]'' research and performs chemical ''Cannabis'' [[laboratory]] testing for the country's various cannabis programs.<ref name="GoCLab18">{{cite web \|url=https://www.canada.ca/en/health-canada/services/list-licensed-dealers.html \|title=Laboratories licensed to conduct activities with cannabis \|work=Health Canada \|publisher=Government of Canada \|date=17 August 2018 \|accessdate=27 June 2019}}</ref>

	==History==		==History==
	The company was formally founded in June 2014.<ref name="CACLACan">{{cite web \|url=https://beta.canadasbusinessregistries.ca/search/results?search={Cannevert}&status=Active \|title=Cannevert Therapeutics Ltd \|work=Canada's Business Registries \|publisher=Canadian Association of Corporate Law Administrators \|accessdate=28 June 2019}}</ref> In December 2015, Veritas Pharma, Inc., "an early stage pharmaceutical company developing innovative medicinal cannabis cultivars for specific disease conditions," announced it would begin investing in Cannevert.<ref name="VeritasVeritas16">{{cite web \|url=http://veritaspharmainc.com/2016/02/16/veritas-presents-its-key-cannevert-scientists/ \|title=Veritas Presents Its Key Cannevert Scientists \|publisher=Veritas Pharma, Inc \|date=16 February 2016}}</ref> By May 2017, Veritas owned 80 percent of Cannevert, with an option to wholly buy the company on the table.<ref name="TNVeritas17">{{cite web \|url=https://thenewswire.com/archives/BKRFNmWA-veritas-pharma-places-final-payment-in-trust-for-the-acquisition-of-cannevert-therapeutics.html \|title=Veritas Pharma Places final Payment in Trust for the Acquisition of Cannevert Therapeutics \|author=Veritas Pharma, Inc \|work=TheNewswire \|date=25 January 2017 \|accessdate=28 June 2019}}</ref> In March 2018, Veritas announced the full acquisition of Cannevert, stating that the acquisition "will further enhance and extend the Company's product offering through development of the most effective cannabis strains, advancing the science behind medical cannabis, providing distribution channels for the Companies patent protected IP (cultivars & strains) products and sell or license to cancer clinics, in Canada, the US, and Europe."<ref name="GNWVeritas18">{{cite web \|url=https://www.globenewswire.com/news-release/2018/03/21/1443325/0/en/Veritas-Pharma-Completes-the-100-Takeover-of-Cannevert-Therapeutics.html \|title=Veritas Pharma Completes the 100% Takeover of Cannevert Therapeutics \|author=Veritas Pharma, Inc \|work=GlobeNewswire \|date=21 March 2018 \|accessdate=28 June 2019}}</ref>		The company was formally founded in June 2014.<ref name="CACLACan">{{cite web \|url=https://beta.canadasbusinessregistries.ca/search/results?search={Cannevert}&status=Active \|title=Cannevert Therapeutics Ltd \|work=Canada's Business Registries \|publisher=Canadian Association of Corporate Law Administrators \|accessdate=28 June 2019}}</ref> In December 2015, Veritas Pharma, Inc., "an early stage pharmaceutical company developing innovative medicinal cannabis cultivars for specific disease conditions," announced it would begin investing in Cannevert.<ref name="VeritasVeritas16">{{cite web \|url=http://veritaspharmainc.com/2016/02/16/veritas-presents-its-key-cannevert-scientists/ \|title=Veritas Presents Its Key Cannevert Scientists \|publisher=Veritas Pharma, Inc \|date=16 February 2016}}</ref> By May 2017, Veritas owned 80 percent of Cannevert, with an option to wholly buy the company on the table.<ref name="TNVeritas17">{{cite web \|url=https://thenewswire.com/archives/BKRFNmWA-veritas-pharma-places-final-payment-in-trust-for-the-acquisition-of-cannevert-therapeutics.html \|title=Veritas Pharma Places final Payment in Trust for the Acquisition of Cannevert Therapeutics \|author=Veritas Pharma, Inc \|work=TheNewswire \|date=25 January 2017 \|accessdate=28 June 2019}}</ref> In March 2018, Veritas announced the full acquisition of Cannevert, stating that the acquisition "will further enhance and extend the Company's product offering through development of the most effective cannabis strains, advancing the science behind medical cannabis, providing distribution channels for the Companies patent protected IP (cultivars & strains) products and sell or license to cancer clinics, in Canada, the US, and Europe."<ref name="GNWVeritas18">{{cite web \|url=https://www.globenewswire.com/news-release/2018/03/21/1443325/0/en/Veritas-Pharma-Completes-the-100-Takeover-of-Cannevert-Therapeutics.html \|title=Veritas Pharma Completes the 100% Takeover of Cannevert Therapeutics \|author=Veritas Pharma, Inc \|work=GlobeNewswire \|date=21 March 2018 \|accessdate=28 June 2019}}</ref> In May 2019, Veritas announced a restructuring and rebuilding of Cannevert, one that would include cutting and rehiring some researchers on a contract basis. Veritas described the move as one that would "reduce costs" while scaling to better tackle analytical testing of ''Cannabis''.<ref name="GNWVeritas19">{{cite web \|url=https://www.globenewswire.com/news-release/2019/05/15/1825699/0/en/Veritas-Announces-Restructuring-of-Cannevert-Therapeutics-Ltd.html \|title=Veritas Announces Restructuring of Cannevert Therapeutics Ltd. \|author=Veritas Pharma, Inc \|work=GlobeNewswire \|date=15 May 2019 \|accessdate=28 June 2019}}</ref>

	In May 2019, Veritas announced a restructuring and rebuilding of Cannevert, one that would include cutting and rehiring some researchers on a contract basis. Veritas described the move as one that would "reduce costs" while scaling to better tackle analytical testing of ''Cannabis''.<ref name=~~"GNWVeritas19">{{cite web \|url~~=~~https~~://www.~~globenewswire~~.com/~~news-release/2019/05/15/1825699/0/en/Veritas-Announces-Restructuring-of~~-~~Cannevert-Therapeutics-Ltd~~.html ~~\|title=Veritas Announces Restructuring of~~ Cannevert Therapeutics ~~Ltd. \|author~~=~~Veritas Pharma, Inc \|work~~=~~GlobeNewswire \|date~~=~~15 May 2019 \|accessdate~~=~~28 June 2019}}</ref>~~		==Locations==
			The following laboratory locations are known. Services may vary among locations:

			* [http://www.cannevert.com/contact-us.html Cannevert Therapeutics] - Vancouver, British Columbia

			==Pricing==
			The company doesn't make its cannabis testing pricing public.

	==Additional information==		==Additional information==
Line 52:		Line 58:

	<!---Place all category tags here-->		<!---Place all category tags here-->
	[[Category:~~Inactive vendors~~]]		[[Category:Cannabis testing laboratories]]
			[[Category:Labs in British Columbia]]
			[[Category:Labs in Canada]]
			[[Category:Vendors]]

Shawndouglas: Made inactive.

2023-12-19T19:00:57Z

Made inactive.

← Older revision		Revision as of 19:00, 19 December 2023
Line 1:		Line 1:
	{{~~cannaqawiki:~~:Cannevert Therapeutics Ltd.}}		{{Infobox company
	==~~Notes~~==		\|company_name = '''Cannevert Therapeutics Ltd.'''
	~~This article is a direct transclusion~~ of [https://www.~~cannaqa~~.~~wiki~~/~~index~~.~~php?~~title=~~Cannevert_Therapeutics_Ltd.~~ the ~~CannaQAwiki article]~~ and ~~therefore may not meet~~ the ~~same editing standards~~ as ~~LIMSwiki~~.		\|company_logo =
			\|company_type = Incorporated (limited)
			\|traded_as =
			\|industry = [[Cannabis industry]]
			\|genre = ''Cannabis'' testing and research
			\|fate =
			\|predecessor =
			\|successor =
			\|company_slogan =
			\|foundation =
			\|founder =
			\|defunct = May 2019<ref name="GNWVeritas19" />
			\|location_city = 101-2386 East Mall, Vancouver, British Columbia
			\|location_country = Canada
			\|locations = 1
			\|area_served = Canada
			\|key_people = John Coleman
			\|products =
			\|production =
			\|services = ''Cannabis'' testing and research
			\|revenue =
			\|operating_income =
			\|net_income =
			\|aum =
			\|assets =
			\|equity =
			\|owner =
			\|num_employees =
			\|parent = Veritas Pharma, Inc.
			\|divisions =
			\|subsid =
			\|homepage = [http://www.cannevert.com/home.html cannevert.com]
			\|linkedin =
			\|footnotes =
			\|intl = No
			}}

			'''Cannevert Therapeutics Ltd.''' conducted ''[[Cannabis]]'' research and performed chemical ''Cannabis'' [[laboratory]] testing for the country's various cannabis programs.<ref name="GoCLab18">{{cite web \|url=https://www.canada.ca/en/health-canada/services/list-licensed-dealers.html \|title=Laboratories licensed to conduct activities with cannabis \|work=Health Canada \|publisher=Government of Canada \|date=17 August 2018 \|accessdate=27 June 2019}}</ref> However, the entity appears to have been a victim of downsizing by parent Veritas Pharma, Inc. in 2019 and no longer appears to operate.

			==History==
			The company was formally founded in June 2014.<ref name="CACLACan">{{cite web \|url=https://beta.canadasbusinessregistries.ca/search/results?search={Cannevert}&status=Active \|title=Cannevert Therapeutics Ltd \|work=Canada's Business Registries \|publisher=Canadian Association of Corporate Law Administrators \|accessdate=28 June 2019}}</ref> In December 2015, Veritas Pharma, Inc., "an early stage pharmaceutical company developing innovative medicinal cannabis cultivars for specific disease conditions," announced it would begin investing in Cannevert.<ref name="VeritasVeritas16">{{cite web \|url=http://veritaspharmainc.com/2016/02/16/veritas-presents-its-key-cannevert-scientists/ \|title=Veritas Presents Its Key Cannevert Scientists \|publisher=Veritas Pharma, Inc \|date=16 February 2016}}</ref> By May 2017, Veritas owned 80 percent of Cannevert, with an option to wholly buy the company on the table.<ref name="TNVeritas17">{{cite web \|url=https://thenewswire.com/archives/BKRFNmWA-veritas-pharma-places-final-payment-in-trust-for-the-acquisition-of-cannevert-therapeutics.html \|title=Veritas Pharma Places final Payment in Trust for the Acquisition of Cannevert Therapeutics \|author=Veritas Pharma, Inc \|work=TheNewswire \|date=25 January 2017 \|accessdate=28 June 2019}}</ref> In March 2018, Veritas announced the full acquisition of Cannevert, stating that the acquisition "will further enhance and extend the Company's product offering through development of the most effective cannabis strains, advancing the science behind medical cannabis, providing distribution channels for the Companies patent protected IP (cultivars & strains) products and sell or license to cancer clinics, in Canada, the US, and Europe."<ref name="GNWVeritas18">{{cite web \|url=https://www.globenewswire.com/news-release/2018/03/21/1443325/0/en/Veritas-Pharma-Completes-the-100-Takeover-of-Cannevert-Therapeutics.html \|title=Veritas Pharma Completes the 100% Takeover of Cannevert Therapeutics \|author=Veritas Pharma, Inc \|work=GlobeNewswire \|date=21 March 2018 \|accessdate=28 June 2019}}</ref>

			In May 2019, Veritas announced a restructuring and rebuilding of Cannevert, one that would include cutting and rehiring some researchers on a contract basis. Veritas described the move as one that would "reduce costs" while scaling to better tackle analytical testing of ''Cannabis''.<ref name="GNWVeritas19">{{cite web \|url=https://www.globenewswire.com/news-release/2019/05/15/1825699/0/en/Veritas-Announces-Restructuring-of-Cannevert-Therapeutics-Ltd.html \|title=Veritas Announces Restructuring of Cannevert Therapeutics Ltd. \|author=Veritas Pharma, Inc \|work=GlobeNewswire \|date=15 May 2019 \|accessdate=28 June 2019}}</ref>

			==Additional information==


			==References==
			<references/>

	<!---Place all category tags here-->		<!---Place all category tags here-->
	[[Category:~~Articles transcluded from other wikis]]~~		[[Category:Inactive vendors]]
	~~[[Category:Cannabis testing laboratories]]~~
	~~[[Category:Labs in Canada~~]]

Shawndouglas: Created as needed.

2020-03-12T16:49:51Z

Created as needed.

New page

{{cannaqawiki::Cannevert Therapeutics Ltd.}}
==Notes==
This article is a direct transclusion of [https://www.cannaqa.wiki/index.php?title=Cannevert_Therapeutics_Ltd. the CannaQAwiki article] and therefore may not meet the same editing standards as LIMSwiki.


[[Category:Articles transcluded from other wikis]]
[[Category:Cannabis testing laboratories]]
[[Category:Labs in Canada]]